Granular Cell Tumor Pathology and Clinical Implications

Granular cell tumours (GCTs) are uncommon neoplasms of presumed Schwann cell origin, identifiable by their characteristic intracytoplasmic eosinophilic granules. They may arise at virtually any anatomical site, most frequently in the skin, oral cavity and alimentary tract. While the vast majority are benign and amenable to complete surgical excision, a small fraction exhibits malignant behaviour with potential for local recurrence and distant metastasis. Histologically, GCTs show sheets of polygonal cells with abundant granular cytoplasm, often accompanied by S-100 protein positivity on immunohistochemical staining. Recent advances in molecular pathology have uncovered recurrent loss-of-function mutations that link impaired endosomal pH regulation to the tumour’s granular phenotype and oncogenic transformation. Clinically, early and accurate diagnosis through imaging, endoscopic techniques or biopsy is essential to guide management, which ranges from simple excision to minimally invasive endoscopic removal in the gastrointestinal tract. In malignant or unresectable cases, targeted therapies aimed at angiogenesis and signalling pathways are emerging as promising options. Together, these developments underscore the importance of integrating molecular insights with evolving diagnostic and therapeutic modalities to optimise patient outcomes on a global scale.

Research from Nature Portfolio

Recent genomic analyses have identified recurrent inactivating mutations in endosomal pH regulators as key oncogenic drivers in granular cell tumours. Functional studies demonstrate that loss of these regulators impairs vesicle acidification, promotes redistribution of endosomal compartments and leads to the accumulation of characteristic cytoplasmic granules. Crucially, these mutations confer proliferative and invasive properties on tumour cells, establishing a direct genotypic–phenotypic correlation. This work has provided the first definitive link between endosomal pH dysregulation and the pathogenesis of GCTs, opening avenues for targeted therapeutic interventions that restore normal vesicular processing or inhibit downstream oncogenic signalling.

Granular Cell Tumor Pathology and Clinical Implications publication trend

The graph below shows the total number of articles in granular cell tumor pathology and clinical implications across all publications each year (not limited to Nature Index journals).

Technical terms

Granular cell tumour: A rare soft tissue neoplasm characterised by cells with abundant cytoplasmic granules.

ATP6AP1/ATP6AP2: Genes encoding subunits of the vacuolar ATPase complex involved in endosomal acidification.

Endosomal pH regulation: The process by which vesicular compartments maintain an acidic environment essential for protein processing.

Endoscopic ultrasound (EUS): A diagnostic modality that combines endoscopy with ultrasonography to visualise and assess gastrointestinal wall layers.

Endoscopic submucosal dissection (ESD): A technique for en bloc removal of superficial gastrointestinal lesions by dissecting the submucosal layer.

Immunohistochemistry: A laboratory method using antibodies to detect specific antigens in tissue sections for diagnostic purposes.

References

1. Antiangiogenics in Malignant Granular Cell Tumors: Review of the Literature. Cancers (2023).
2. Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors. Nature Communications (2018).
3. Endoscopic submucosal dissection of esophageal granular cell tumor. World Journal of Surgical Oncology (2014).